Correlation Between Equillium and Enanta Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Equillium and Enanta Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Enanta Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Enanta Pharmaceuticals, you can compare the effects of market volatilities on Equillium and Enanta Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Enanta Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Enanta Pharmaceuticals.
Diversification Opportunities for Equillium and Enanta Pharmaceuticals
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Equillium and Enanta is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Enanta Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enanta Pharmaceuticals and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Enanta Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enanta Pharmaceuticals has no effect on the direction of Equillium i.e., Equillium and Enanta Pharmaceuticals go up and down completely randomly.
Pair Corralation between Equillium and Enanta Pharmaceuticals
Allowing for the 90-day total investment horizon Equillium is expected to generate 1.85 times more return on investment than Enanta Pharmaceuticals. However, Equillium is 1.85 times more volatile than Enanta Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Enanta Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest 140.00 in Equillium on August 30, 2024 and sell it today you would lose (63.00) from holding Equillium or give up 45.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Equillium vs. Enanta Pharmaceuticals
Performance |
| Timeline |
| Equillium |
| Enanta Pharmaceuticals |
Equillium and Enanta Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Equillium and Enanta Pharmaceuticals
The main advantage of trading using opposite Equillium and Enanta Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Enanta Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enanta Pharmaceuticals will offset losses from the drop in Enanta Pharmaceuticals' long position.| Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
| Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |